Renal transplantation outcome in selected recipients with IgA nephropathy as native disease: A bicentric study

Annals of Transplantation

Volumn 17, Issue 3, 2012, Pages 45-51

  Aziz, Amir Kamal ^a   Mousson, Christiane ^b   Berthoux, Francois ^a   Ducloux, Didier ^c   Chalopin, Jean Marc ^c  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b HÔPITAL DU BOCAGE   (France)

^c HÔPITAL SAINT JACQUES   (France)

Author keywords

IgA nephropathy; Native disease; Recurrence

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MESANGIUM; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PROTEINURIA; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL RATE;

EID: 84868701001     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/aot.883457     Document Type: Article

References (29)

1. Berthoux F, Mohey H, Afiani A: Natural history of primary IgA Nephropathy. Seminar Nephrol, 2008; 28: 4-9
2. Boyd JK, Cheung CK, Molyneux K et al: An update on the pathogenesis and treatment of IgA nephropathy. Kidney Int, 2012; 81(9): 833-43
3. Berger J, Yaneva H, Nabarra B, Barbanel C: Recurrence of mesangial deposition of IgA after renal transplantation. Kidney Int, 1975; 7: 232-41
4. Frohnert PP, Donadio JV Jr, Velosa JA et al: The fate of renal transplants in patients with IgA nephropathy. Clin Transplant, 1997; 11: 127-33
5. Ohmacht Ch, Kliem V, BurgM et al: Recurrent immunoglobulin A nephropathy after renal transplantation: a significant contributor to graft loss. Transplantation, 1997; 64: 1493-96
6. Kessler M, Hiesse C, Hestin D et al: Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporine era. Am J Kidney Dis, 1996; 28: 99-104
7. Floege J, Burg M, Kliem V: Recurrent IgA nephropathy after kidney transplantation: not a benign condition. Nephrol Dial Transplant, 1998; 13: 1933-35
8. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG: Single center long-term results of renal transplantation for IgA nephropathy. Transplantation, 1998; 65: 1053-60
9. Freese P, Svalander C, Norden G, Nyberg G: Clinical risk factors for recurrence of IgA nephropathy. Clin Transplant, 1999; 13: 313-17
10. Ponticelli C, Traversi L, Feliciani A et al: Kidney transplantation in patients with IgA mesangial glomerulonephritis. Kidney Int, 2001; 60: 1948-54
11. Wang AYM, Lai FM, Yu AWY et al: Recurrent IgA Nephropathy in renal transplant allografts. Am J Kidney Dis, 2001; 38: 588-96
12. Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF: Favorable outcome of renal transplantation in patients with IgA nephropathy. Clin Nephrol, 2001; 56: 279-88
13. Briganti EM, Russ GR, McNeil JJ et al: Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med, 2002; 347: 103-9
14. Choy BY, Chan TM, Lo SK et al: Renal transplantation in patients with primary immunoglobulin A nephropathy. Nephrol Dial Transplant, 2003; 18: 2399-404
15. Soler MJ, Mir M, Rodriguez E et al: Recurrence of IgA nephropathy and Henoch-Schonlein purpura after kidney transplantation: Risk factors and graft survival. Transplant Proc, 2005; 37: 3705-9
16. Moriyama T, Nitta K, Suzuki K et al: Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation. Clin Transplant, 2005; 19: S41-48
17. Pascual J, Mezrich J, Djamali A et al: Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation. Transplantation, 2007; 83: 1429-34
18. Berthoux F, El Deeb S, Mariat C et al: Antithymocyte globulin (ATG) induction therapy and disease recurrence in renal transplantation recipients with primary IgA nephropathy. Transplantation, 2008; 85: 1505-7
19. Mulay AV, Van Walraven C, Knoll GA: Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. Am J Transplant, 2009; 9: 804-11
20. Clayton P, McDonald S, Chadban S: Steroids and recurrent IgA nephropathy after kidney transplantation. Am J Transplant, 2011; 11: 1645-49
21. Bjorneklett R, Vikse BE, Smerud HK et al: Pretransplant course and risk of kidney transplant failure in IgA nephropathy patients. Clin Transplant, 2011; 25: E356-65
22. Mousson C, Charon-Barra C, Funes de la Vega M et al: Recurrence of IgA nephropathy with crescents in kidney transplants. Transplant Proc, 2007; 39: 2595-96
23. Tang Z, Ji SM, Chen DR et al: Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation. Ren Fail, 2008; 30: 611-16
24. Alamartine E, Boulharouz J, Berthoux F: Actuarial survival rate of kidney transplants in patients with IgA glomerulonephritis: a one-center study. Transplant Proc, 1994; 26: 272
25. Bonnet F, Deprele C, Sassolas A et al: Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis, 2001; 37: 720-27
26. Oka K, Imai E, Moriyama T et al: A clinicopathological study of IgA nephropathy in renal transplant recipients: Beneficial effect of angiotensin-converting. Nephrol Dial, Transplant, 2000; 15: 689-95
27. Berthoux F, Mohey H, Laurent B et al: Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol, 2011; 22: 752-61
28. Del Prete D, Gambaro G, Lupo A et al: Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney Int, 2003; 64: 149-59
29. Lufft V, Kliem V, Hamkens A et al: Antiproteinuric efficacy of fosinopril after renal transplantation is determined by the extent of vascular and tubulo-interstitial damage. Clin Transplant, 1998; 12: 409-15